New Markers of Glycation to Predict Gestational Diabetes Mellitus and Macrosomia.

NARecruitingINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

December 18, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Macrosomia, FetalGestational Diabetes Mellitus in Pregnancy
Interventions
DIAGNOSTIC_TEST

Pregnant women

"Gestational Diabetes Mellitus increases the risk of adverse pregnancy outcomes (such as macrosomia).~The lack of early clinical symptoms leads to screen pregnant women for GDM, and the strategies of screening are a matter of debate.~Interventions to control glucose levels in women with GDM have demonstrated efficacy in terms of macrosomia. However, macrosomia may start before the time of screening, suggesting that markers of glycation may have interest : skin autofluorescence, glycated albumin."

Trial Locations (1)

33000

RECRUITING

Hopital Pellegrin, Bordeaux

All Listed Sponsors
collaborator

Société Francophone du Diabète

OTHER

lead

University Hospital, Bordeaux

OTHER